Profarma Distribuidora de Produtos Farmacêuticos S.A.

São Paulo Stock Exchange PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio for the year ending December 31, 2023: 0.92

Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio is 0.92 for the year ending December 31, 2023, a 6.54% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio for the year ending December 31, 2022 was 0.86, a -1.37% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio for the year ending December 31, 2021 was 0.87, a 1.28% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio for the year ending December 31, 2020 was 0.86, a 29.44% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Debt to Equity Ratio for the year ending December 31, 2019 was 0.67, a 6.79% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
São Paulo Stock Exchange: PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A.

CEO Mr. Sammy Birmarcker
IPO Date Oct. 26, 2006
Location Brazil
Headquarters Avenida Ayrton Senna 2.150
Employees 7,077
Sector Healthcare
Industries
Description

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.

Similar companies

TCSA3.SA

Tecnisa S.A.

USD 0.27

2.48%

POSI3.SA

Positivo Tecnologia S.A.

USD 0.98

0.88%

JHSF3.SA

JHSF Participações S.A.

USD 0.67

-1.25%

ODPV3.SA

Odontoprev S.A.

USD 1.94

0.70%

StockViz Staff

February 4, 2025

Any question? Send us an email